Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6468875 | 0.93 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL9883306 | 0.93 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL12966441 | 0.91 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL25916046 | 0.91 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL23740155 | 0.90 | KDM4E (0.33) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL14235019 | 0.89 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL21319866 | 0.89 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL19801310 | 0.89 | PTGER4 (0.34) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL23740139 | 0.88 | — | — | |
| SCHEMBL21320443 | 0.88 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10833276-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-11-10 | — | — | US | disclosed |
| US-20180145262-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10833276-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, TYR | KDM4E 3046/4885ATM 590/4885L3MBTL1 239/4885 |
| US-20180145262-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, TYR | KDM4E 3046/4885ATM 590/4885L3MBTL1 239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.